Young Adult Males' Perspectives of Male Hormonal Contraception

Megan R. Sax, MD; Emily G. Hurley, MD; Rocco A. Rossi, MD, MA; Suruchi Thakore, MD; Abhinav Hasija, PhD; Julie Sroga-Rios, MD


South Med J. 2021;114(2):73-76. 

In This Article


A total of 162 eligible surveys were completed, 92 in the UC population and 70 in the CHD population. An additional 11 surveys in the CHD population were collected; however, they did not meet the inclusion criteria. All of the surveys submitted by the UC population met the inclusion criteria for statistical analysis. Individuals in the UC population were statistically more likely to be in a relationship, have children, and consistently use contraception. The UC population was also significantly more likely to have achieved a higher degree of education (Table 1).

Of all of the survey participants, 45% would use MHC, whereas 30.9% were unsure and 23.5% would not use MHC. Overall, the UC survey population was significantly more likely to be interested in using MHC than the CHD population. Between both groups, 56.1% participants preferred the injectable MHC and 35.0% selected the daily birth control pills as the preferred method (Table 2).

The possible concerning factors deterring survey participants from using MHC included failure of contraception, potential adverse effects, accessibility, and cost (Table 2). Cited concerns were found to be statistically significant between the two populations surveyed, with UC participants having more frequent concerns (62.6%) about the possible failure of the contraceptive method, whereas CHD participants had more frequent concerns (40%) about the potential adverse effects (40%, P < 0.001).